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SummaryThe nuclear intermediate filament protein lamin A/C acts cell-autonomously in hepatocytes as a positive regulator of growth hormone signaling and maintains hepatocyte homeostasis and nuclear shape. Lamin A/C absence leads to male-selective fatty liver disease and predisposes to nonalcoholic steatohepatitis and fibrosis.

Nuclear lamins are type V intermediate filament proteins that play important roles in maintaining nuclear stability and regulating gene expression, and they also serve as signaling scaffolds at the inner nuclear membrane.[@bib1], [@bib2] Lamins are classified based on their isoelectric points and sequence homology as A- or B-type lamins. *LMNA* (in human beings; *Lmna* in mice) encodes the alternatively spliced lamins A and C, and lamins B1 and B2 are encoded by *LMNB1* and *LMNB2*, respectively.[@bib3], [@bib4], [@bib5]

Lamin B1 is expressed ubiquitously, whereas lamin A/C is expressed postnatally in differentiated cells, including cardiac and skeletal muscle, adipocytes, and hepatocytes.[@bib6], [@bib7], [@bib8] Lamin A/C binds to chromatin, lamina-associated proteins, and signaling mediators, such as extracellular signal--regulated kinase (Erk), c-Fos, retinoblastoma protein, and sterol regulatory element-binding protein-1c, to regulate gene expression and cell signaling.[@bib9], [@bib10], [@bib11] Mutations in lamin A/C cause several human diseases, termed *laminopathies*, that can affect muscle (eg, Emery--Dreifuss muscular dystrophy), adipose tissue, liver (eg, Dunnigan familial partial lipodystrophy \[FPLD2\]), bone (eg, mandibuloacral dysplasia), or multiple tissues (eg, Hutchinson--Gilford progeria syndrome), depending on the site of the mutation.[@bib12], [@bib13]

FPLD2 (OMIM [151660](151660){#intref0015}) is characterized by partial lipodystrophy and metabolic syndrome, including insulin resistance, glucose intolerance, and hypertriglyceridemia.[@bib14], [@bib15], [@bib16], [@bib17] Hepatosteatosis occurs in many patients with FPLD2 and other lipodystrophies and may progress to steatohepatitis.[@bib18], [@bib19]

The mechanism by which lipodystrophy-associated lamin mutations promote hepatic steatosis and metabolic syndrome is unclear. One possibility is that lamin A/C is dispensable in hepatocytes and, if so, the liver simply serves as a storage depot for excess fatty acids shunted into the circulation as a result of adipose tissue loss. Alternatively, FPLD2-associated lamin A/C variants in hepatocytes might directly promote fatty acid uptake and/or lipogenesis in the liver.

Previous characterization of laminopathy mouse models focused on adipose and muscle tissues. For example, characterization of mice transgenic for a *LMNA* mutation that causes FPLD2 focused primarily on its effect on adipose tissue, using the adipocyte protein 2 enhancer, which directs overexpression to adipose tissues, and showed a defect in adipose tissue renewal.[@bib20] In addition, assessment of total-body *Lmna-*deficient mice showed normal fat distribution and metabolism in heterozygous mice. However, complete characterization of a potential FPLD2 phenotype in homozygous mice was prevented by severe muscular dystrophy that became lethal by 8 weeks of age.[@bib21], [@bib22]

To characterize the role of lamin A/C specifically in the liver, we generated mice carrying hepatocyte-specific deletion of *Lmna*, using mice carrying a *Lmna* allele with loxP sites.[@bib23] We found that hepatocyte lamin A/C deficiency induced spontaneous liver injury and steatosis and led to markedly increased susceptibility to steatohepatitis upon feeding a high-fat diet (HFD) in a male-specific manner that correlated with the up-regulation of genes encoding fatty acid binding proteins, lipogenic enzymes, and lipid transporters. Notably, lamin A/C deficiency disrupted hepatic growth hormone (GH)-receptor signaling through the Janus kinase 2 (Jak2), Erk, and signal transducer and activator of transcription (Stat)5 axes, leading to dysregulation of downstream Stat5-dependent gene transcription, with up-regulated expression of Stat1 and downstream interferon-regulated genes. Hepatic GH signaling regulates liver metabolism and gender-specific hepatic gene expression in rodents and human beings.[@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30] Our findings show that lamins help maintain hepatocyte homeostasis cell-autonomously and regulate hepatic growth hormone signaling. Lamin A/C genetic variants potentially may contribute to the development and/or progression of nonalcoholic fatty liver disease (NAFLD), which is becoming a major global liver disease.[@bib31]

Materials and Methods {#sec1}
=====================

Antibodies {#sec1.1}
----------

The antibodies used were as follows: lamin A/C (H-110; Santa Cruz Biotechnology, Santa Cruz, CA); lamin B1 (ab16048; Abcam, Cambridge, UK); phosphorylated Stat5 (9314S), total Stat5 (9363S), phosphorylated Jak2 (3771S), total Erk (clone L34F12), phosphorylated Erk (4370P), total Akt (clone 40D4), total Jak2 (clone D2E12), phosphorylated Akt (4058S), total Stat1 (clone D1K9Y), and phosphorylated Stat1 (clones D4A7 and 58D6) (Cell Signaling Technology, Danvers, MA); pan-actin (Ab-5, 1:2500 dilution; ThermoFisher Scientific, Wayne, MI); and CD45 (clone 30-F11, 1:200 dilution; BD Biosciences, San Jose, CA). All antibodies were used at a 1:1000 dilution unless specified otherwise.

Mouse Experiments {#sec1.2}
-----------------

Mouse experiments were performed in accordance with guidelines outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and published by the National Institutes of Health, and with approval from the University of Michigan Institutional Animal Care and Use Committee. C57BL/6 mice with a floxed allele of *Lmna*[@bib23] were crossed to C57BL/6 albumin-Cre mice[@bib32] to generate C57BL/6 offspring with hepatocyte-specific deletion of exons 10 and 11 of *Lmna* and littermate control mice that either lacked the floxed *Lmna* allele or the albumin-Cre transgene. Both male and female mice were used and ranged in age from 8 to 39 weeks. Mice were fed normal chow or the high-fat Surwit Diet (Research Diets, Inc, New Brunswick, NJ) plus water containing 42 g/L of carbohydrates at 55% fructose and 45% sucrose (Sigma Aldrich, St. Louis, MO) for 14 weeks.[@bib33] For GH injection experiments, mice were fasted for 6 hours and then injected intraperitoneally with phosphate-buffered saline (PBS) or GH in PBS (2.5 mg/kg) followed by euthanasia and harvesting of the livers 10 minutes after GH administration. Mice were euthanized by CO~2~ asphyxiation. Blood was collected by intracardiac puncture, and livers were harvested for paraffin embedding (after fixation in 10% formalin) and immunohistochemistry or were frozen in optimum cutting temperature compound (OCT; ThermoFisher Scientific) for immunofluorescence staining. Mice and whole livers were weighed before liver processing to calculate the liver percentage of body mass (% liver weight). Serum alanine aminotransferase and serum triglyceride values were determined by the Unit for Laboratory Animal Medicine at the University of Michigan.

Microarray Analysis {#sec1.3}
-------------------

Total RNA from *Lmna* wild-type (WT), heterozygous (Het), and knockout (KO) male livers from normal diet (ND)- and HFD-fed mice was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). RNA was hybridized to Mouse Gene ST 2.1 plates (Affymetrix, Santa Clara, CA) using the GeneChip WT PLUS Reagent Kit (Affymetrix).

Immunofluorescence Staining, Immunohistochemistry, and Transmission Electron Microscopy {#sec1.4}
---------------------------------------------------------------------------------------

Six-micron frozen mouse liver sections were fixed in methanol (-20°C, 10 min), washed with PBS, and then permeabilized (22°C, 3 min) with 0.1% Triton X-100 (Sigma Aldrich, St. Louis, MO) in PBS. Sections were blocked with 2% goat serum in 2% bovine serum albumin/PBS for 30 minutes and incubated overnight with a 1:50 dilution of the primary antibody followed by a 1-hour incubation with Alexa Fluor--488 goat anti-rabbit IgG (Life Technologies, Carlsbad, CA) (1:500). Slides were mounted using Prolong Gold Anti-fade Reagent with 4′,6-diamidino-2-phenylindole (ThermoFisher Scientific), and stained sections were visualized with the Axioimager M2 microscope (Zeiss, Pleasanton, CA). For immunohistochemistry, formalin-fixed, paraffin-embedded liver sections were rehydrated via sequential incubations in xylene, ethanol, and water. Sections then were heated in Citra antigen-retrieval solution (Biogenex, Fremont, CA) for 8 minutes, washed, and treated for 15 minutes with 0.6% H~2~O~2~ in methanol. Nonspecific antibody binding was blocked using 5% normal goat serum/2.5% bovine serum albumin in PBS (30 minutes). Primary antibody incubation was performed overnight at 4°C at 1:200 dilution in blocking buffer. Detection was performed with the Vectastain ABC rat IgG kit (Vector Laboratories, Burlingame, CA). Slides were developed using 3,3′-diaminobenzidine tetra hydrochloride substrate reagent (Vector Laboratories), counterstained with hematoxylin, dehydrated with ethanol and xylene, and then mounted with coverslips for analysis. Picrosirius red, Oil Red O, and immunohistochemistry staining was visualized using a LMD7000 microscope (Leica, Wetzlar, Germany). Transmission electron microscopy of livers from WT and KO mice was performed as described.[@bib34]

Sample Fractionation and Immunoblotting {#sec1.5}
---------------------------------------

Total tissue homogenates were obtained by dounce homogenization of frozen liver samples in homogenization buffer (0.187 mol/L Tris, 3% sodium dodecyl sulfate, and 5 mmol/L EDTA, pH 6.8). Cytoplasmic and nuclear extracts were obtained from isolated primary hepatocytes and whole livers using NE-PER Nuclear and Cytoplasmic Extraction Reagents (ThermoFisher Scientific). For analysis of GH signaling in liver cytoplasmic extracts, scans of immunoblots were obtained using the ChemiDoc Touch Imaging System (Bio-Rad Laboratories, Hercules, CA), and relative band intensities were estimated using ImageJ version 1.51j8 software (National Institutes of Health, Bethesda, MD). Relative band intensities for phosphorylated Erk, Jak2, Stat5, and Akt were normalized against total Erk, Jak2, Stat5, and Akt, respectively.

Oil Red O Staining and Quantification {#sec1.6}
-------------------------------------

Ten-micron frozen liver sections were fixed in ice-cold 10% formalin (10 min), rinsed with water (3×), air dried, and incubated in absolute propylene glycol (Sigma Aldrich) for 5 minutes before staining with 0.5% Oil Red O (Sigma Aldrich) in propylene glycol (60°C, 10 min). Stained slides were washed in 85% propylene glycol and then water before counterstaining with Gill's 3 Hematoxylin (Sigma Aldrich) for 30--45 seconds. Stained slides then were washed thoroughly with water (3 min) and mounted using glycerol gelatin (Sigma Aldrich). Eight to 10 fields/liver section (10× objective on a Leica LMD7000) were imaged for analysis. The percentage of Oil Red O--stained area was determined using Metamorph Image Analysis Software (Molecular Devices, Sunnyvale, CA).

Hydroxyproline Determination {#sec1.7}
----------------------------

Hydroxyproline measurement was performed as described previously.[@bib35] Absorbance (570 nm) readings were taken using a Synergy 2 Multi-Mode Reader (BioTek, Winooski, VT), and values were normalized to microgram of hydroxyproline per gram of liver weight.

Picrosirius Red Staining {#sec1.8}
------------------------

Picrosirius red staining of formalin-fixed paraffin sections of livers from 23-week-old mice was performed by the Unit for Laboratory Animal Medicine at the University of Michigan. Subsequent Picrosirius red staining for 30- to 35-week-old mice was performed as follows: 5-μm paraffin sections were stained in 0.1% Picrosirius red in saturated picric acid for 1 hour, washed twice with 0.5% acetic acid, dehydrated in 3 changes of 100% ethanol, cleared in xylene, and mounted in Permount (ThermoFisher Scientific). Eight to 10 fields/liver section (10× objective using a Leica LMD7000) were imaged for analysis. The percentage of Picrosirius red--stained area was determined using Metamorph Image Analysis Software (Molecular Devices).

Reverse-Transcription Polymerase Chain Reaction {#sec1.9}
-----------------------------------------------

Total RNA was isolated from mouse livers using the RNeasy Mini Kit (Qiagen). Complementary DNA was prepared using the TaqMan Reverse-Transcription Reagents kit (Roche, Branchburg, NJ). Quantitative polymerase chain reaction (qPCR) was performed using Mastercycler realplex (Eppendorf, Hauppauge, NY). The reaction parameters were as follows: 95°C for 3 minutes; 40 cycles of 95°C for 15 seconds, 60°C for 30 seconds, and 72°C for 30 seconds. The relative expression was determined using the 2^-ΔΔCt^ method.[@bib36] The list of qPCR primers is included in [Table 1](#tbl1){ref-type="table"}.Table 1Oligonucleotides Used in qPCR AnalysisPrimerForwardReverseActa2TCAGCGCCTCCAGTTCCTAAAAAAAACCACGAGTAACAAATCAACd36GCTGCACCACATATCTACCAAAAGGATATGGAACCAAACTGAGGCideaCAGTCTGCAAGCAACCAAAGTTGTGCATCGGATGTCGTAGCidecAGCTAGCCCTTTCCCAGAAGCCTTGTAGCAGTGCAGGTCACol1TCTGACTGGAAGAGCGGAGAGGGCACAGACGGCTGAGTAGGCyp2a4AGCAGGCTACCTTCGACTGGGCTGCTGAAGGCTATGCCATCyp2b13GAACTGAGACTACCAGCACCACTCTTGAGCATGAGCAGGAAACCACTCyp2b9CTGAGACCACAAGCGCCACCTTGAGCATGAGCAGGACTCCCyp39a1TTCTGGAACCCTCTTGCAGGCGTGTTTCCGTCTCCACCACCyp7b1CAGAAGTTCAGCAGCCGATTAGTGAGCCACAGAATGCAAAGstπTTGCCGATTACAACTTGCTGATGGGACGGTTCACATGTTCHsd3b5CCAGTGTGCCAACATTCATCAAGTGCCACCATTTTTCAGGIgf1AGGCTATGGCTCCAGCATTGTCTTGGGCATGTCAGTGTGIrf7TGATCTTTCCCAGTCCTGCTTGCCTACCTCCCAGTACACCMogat1TCAAAACGCAGGATTTGGATACAACGGGAAACAGAACCAGMup3TGGGTATTGGTTTTCTATTGCTGCTCCAAGACAGTGATGTTTTCCNnmtGAAGGGACCTGAGAAGGAGGAAGTACCTGCTTGATTGCACGCSlco1aCACCTGTTTACTTTGGCGCTATGAAGACTGCGGGGAGAAAStat1GTGGAGCCCTACACGAAAAAATACTTCCCAAAGGCGTGGTSult1e1TGGACAAACGGTTCACCAAAGCCTTGCCAAGAACATTTCAATgfβGGCCAGATCCTGTCCAAACTTGTTGCGGTCCACCATTAGThemisTGTGAAGGTGGCTGTGAGAGCATCTGCAGGCAAACTGCTATimp1TCCCTTGCAAACTGGAGAGTAGGTGCACAAGCCTGGATTCTnfaCGTCAGCCGATTTGCTATCTCGGACTCCGCAAAGTCTAAGUbdCCTTACCCTGAAGGTGGTGACTTCCAGCTTCTTTCCGTTG18SAAACGGCTACCACATCCAAGCCTCAAATGGATCCTCGTTA

Hepatocyte Isolation and GH Treatment {#sec1.10}
-------------------------------------

Hepatocytes were isolated from age-matched mice for primary culture as described.[@bib37] After 30 minutes (37°C, 5% CO~2~) to allow for attachment, the cell culture media was replaced (to remove any debris or unattached cells) with fresh media. Primary hepatocytes were serum-starved overnight for 8--12 hours and then stimulated with human growth hormone (Nutropin; Genentech, South San Francisco, CA) in William's medium E without serum (37°C, 10 min) at the indicated concentrations.

Statistical Analysis {#sec1.11}
--------------------

Statistical analysis for microarray data was performed using the Oligo and Limma packages of Bioconductor implemented in the R statistical environment. Expression values for each gene in the microarray was calculated using a robust multi-array average.[@bib38] Probe sets with a variance over all samples less than 0.05 were filtered out. *P* values were adjusted for multiple comparisons using false-discovery rate.[@bib39] Statistical analysis of histologic scoring, qPCR, serology, and the percentage of body weight comparisons, body mass comparisons, Oil Red O and Picrosirius red staining, and relative immunoblot band intensities were performed using GraphPad Prism software (GraphPad Software, San Diego, CA). Statistical comparisons were performed using the unpaired *t* test (2-tailed) or 1-way analysis of variance followed by the Tukey post hoc test.

All authors had access to the study data and have reviewed and approved the final manuscript.

Results {#sec2}
=======

Hepatic *Lmna* Deficiency Disrupts Nuclear Morphology {#sec2.1}
-----------------------------------------------------

Mice with hepatocyte-specific *Lmna* deficiency were generated by crossing albumin-Cre transgenic mice with mice carrying a *Lmna* allele containing loxP sites flanking exons 10 and 11. Livers from mice homozygous for the floxed *Lmna* allele and positive for the albumin-Cre transgene (designated KO) expressed dramatically lower levels of lamin A/C compared with WT and Het livers ([Figure 1](#fig1){ref-type="fig"}*A*). Staining for lamin B1, which is located at the inner nuclear membrane, showed abnormal nuclear morphology in male and female KO hepatocytes ([Figure 1](#fig1){ref-type="fig"}*B*), which was supported by electron microscopy findings of misshapen nuclei in KO as compared with WT livers (76% vs 31% abnormal nuclei, respectively) ([Figure 1](#fig1){ref-type="fig"}*C*).Figure 1**Hepatic *Lmna* deficiency disrupts nuclear morphology.** (*A*) Whole--cell extracts from *Lmna* WT, Het, and KO livers were analyzed by immunoblotting using antibodies to lamins A/C and B1. Each *lane* corresponds to a separate liver. Frozen sections from WT and KO livers were fixed in methanol and stained for lamin A/C followed by 4′,6-diamidino-2-phenylindole (DAPI). *Scale bars*: 50 μm. (*B*) Livers of 3 WT and 3 KO males (19--25 weeks of age) and 4 WT and 5 KO females (26--28 weeks of age) were cryosectioned and stained for Lamin B1 and DAPI. Normal-appearing and altered nuclei were counted in a blinded fashion from 5 fields per liver. *Error bars* represent SD, and statistical significance was determined by 1-way analysis of variance followed by the Tukey post hoc test. \*\*\*\**P* \< .0001 and \*\*\**P* = .0005 for WT vs KO males and females, respectively. *Scale bars*: 20 μm for the representative sections shown. (*C*) Livers of 5 WT and 5 KO male mice (age, 22--24 wk) were examined by electron microscopy. Normal-appearing and altered nuclei (as defined by the presence of blebs and deformation) were counted in a blinded fashion from an average of 16 fields/liver. *Error bars* represent SD, and statistical significance (\*\**P* \< .01) was determined using an unpaired *t* test (2-tailed). WT nuclei, n = 142; KO nuclei, n = 278. *Scale bars*: 2 μm for the representative sections shown.

Hepatic *Lmna* Deficiency Promotes Steatosis and Liver Injury in Male, but Not Female, Mice {#sec2.2}
-------------------------------------------------------------------------------------------

To assess the effect of lamin A/C deficiency on liver injury, mice were fed for 14 weeks with ND, or HFD supplemented with sucrose-fructose in the drinking water. In mice fed ND, lamin A/C absence led to spontaneous, male-selective liver injury by 14--17 weeks of age ([Figure 2](#fig2){ref-type="fig"}) and steatosis that progressed with age ([Figure 3](#fig3){ref-type="fig"}) with no change in serum triglyceride levels ([Figure 4](#fig4){ref-type="fig"}*A*). The NAFLD activity histologic scoring[@bib40] of H&E-stained livers ([Figure 3](#fig3){ref-type="fig"}*A*) showed more prominent liver pathology in male KO livers compared with male WT and Het livers, with significantly higher NAFLD activity scores[@bib40] in the KO livers ([Figure 3](#fig3){ref-type="fig"}*A*). No such histologic changes were appreciated in female KO livers under the same conditions (not shown). Both male and female KO animals showed decreased body mass ([Figure 4](#fig4){ref-type="fig"}*B*) without any effect on the % liver weight ([Figure 2](#fig2){ref-type="fig"}). The animals showed no gross morphologic changes (not shown).Figure 2**Hepatic *Lmna* deficiency promotes liver injury in male, but not female, mice fed a normal diet.** Liver-specific lamin A/C KO leads to increased serum alanine aminotransferase (ALT) levels in male, but not female, mice (ages, 14--17 wk; 23--28 wk) fed normal chow (\*\*\*\**P* \< .0001 for WT vs KO and Het vs KO comparisons at 14--17 weeks, and \*\*\**P* \< .001 for both comparisons at 23--28 weeks). n = 8, 10, and 7 for male WT, Het, and KO mice, respectively, and n = 4 for each of the female WT, Het, and KO mice, respectively, at 14--17 weeks. n = 3, 11, and 5 for male WT, Het, and KO mice, respectively, and n = 3 for each of the female WT, Het, and KO mice, respectively, at 23--28 weeks. For the 23- to 28-week group, the % liver weight is shown. NS, no significant differences in ALT values between genotypes for female livers and no significant difference in the % liver weight between genotypes for both sexes.Figure 3**Hepatic *Lmna* deficiency promotes hepatosteatosis in male mice in an age-dependent manner.** (*A*) Livers from male mice of the indicated genotypes (18--24 and 34--39 weeks of age) were fixed and then stained with H&E. *Arrows* indicate steatosis. *Scale bars*: 100 μm. NAFLD activity scores were determined in a blinded fashion for WT (n = 9), Het (n = 8), and KO (n = 13) livers at 18--24 weeks (*upper panel*) and for WT (n = 4), Het (n = 4), and KO (n = 8) livers at 34--39 weeks (*lower panel*). *Error bars* represent the SD. Mean values are shown under each graph. \*\*\**P* \< .001 and \*\*\*\**P* \< .0001. (*B*) Frozen liver sections (10 μm) from ND male WT and KO livers at 15 and 28 weeks of age were stained with Oil Red O, showing lipid accumulation in the KO liver. *Scale bars*: 200 μm.Figure 4**Hepatic *Lmna* deficiency has no effect on serum triglyceride levels but reduces body mass.** (*A*) Hepatocyte-specific *Lmna* deficiency has no effect on serum triglyceride levels with ND feeding conditions at 15 and 22 weeks of age. (*B*) Male and female KO mice (19--24 weeks of age) showed reduced body mass compared with their WT counterparts. The mean body mass in grams for each group is shown below each graph. \*\**P* \< .01 for WT vs KO males, and \**P* \< .05 for WT vs KO females.

The difference between WT and KO male and female mice became even more apparent after HFD feeding, which led to neutral fat accumulation (based on H&E and Oil Red O staining) ([Figure 5](#fig5){ref-type="fig"}), liver injury ([Figure 6](#fig6){ref-type="fig"}*A*), hepatomegaly ([Figure 6](#fig6){ref-type="fig"}*A* and *B*), nodularity ([Figure 6](#fig6){ref-type="fig"}*B*), and body mass decrease ([Figure 6](#fig6){ref-type="fig"}*C*) in male, but not female, KO mice. H&E staining of male KO livers after HFD feeding ([Figure 5](#fig5){ref-type="fig"}*A*) showed extensive steatotic changes with inflammatory infiltrates and significantly higher NAFLD activity scores compared with WT and Het livers (with all KO livers receiving scores \>4, indicating steatohepatitis). Despite the increase in hepatic steatosis in *Lmna*-deficient male mice, serum triglyceride levels in WT and KO mice were equivalent under both ND and HFD conditions ([Figures 4](#fig4){ref-type="fig"}*A* and [6](#fig6){ref-type="fig"}*D*).Figure 5**Hepatic *Lmna* deficiency leads to steatohepatitis after HFD feeding.** (*A*) HFD induces steatosis and lobular hepatitis to a much greater degree in KO compared with WT livers based on H&E staining. *Scale bars*: 100 μm. NAFLD activity scores were determined for WT (n = 7), Het (n = 12), and KO (n = 6) livers from mice ranging in age from 23 to 32 weeks (23--32 weeks for WT, 23--32 weeks for Het, and 23--25 weeks for KO) in a blinded fashion. \*\**P* \< .01 for WT vs KO and Het vs KO. *Arrows* indicate steatosis; *arrowhead* indicates a focus of lobular hepatitis. (*B*) Frozen liver sections from male and female (WT/Het/KO) livers were stained with Oil Red O (ORO), and the percentage of stained area was calculated as described in the Materials and Methods section (\**P* \< .05). *Scale bars*: 200 μm. Each *point* represents data from a separate mouse liver. Male mice were 22--23 weeks of age, and female mice were 27--31 weeks of age. (*C*) Paraffin sections of livers from HFD-fed male (age, 23 wk) and female (age, 31 wk) WT and KO mice were stained with H&E. *Scale bars*: 200 μm.Figure 6**Hepatic *Lmna* deficiency promotes liver hypertrophy and nodularity and body mass decrease after HFD feeding in a male-specific manner.** (*A*) HFD led to an increase in alanine aminotransferase (ALT) levels in male, but not female, lamin A/C KO mice for those ages 23--28 and 30--35 weeks. For mice ages 23--28 weeks, n = 4, 9, and 6 for the male WT, Het, and KO mice, respectively; and n = 5 and 3 for female Het and KO, respectively. For mice ages 30--35 weeks, n = 4, 7, and 4 for male WT, Het, and KO, respectively; and n = 4, 5, and 6 for female WT, Het, and KO, respectively. The percentage of liver weights for mice ages 23--28 and 30--35 weeks were more prominently different in KO male livers compared with WT and Het male livers, as compared with WT vs KO female livers. *Error bars* in all graphs represent SD. Statistical significance was determined using 1-way analysis of variance followed by the Tukey post hoc test (\**P* \< .05, \*\**P* \< .01, and \*\*\*\**P* \< .0001). (*B*) Gross hepatomegaly and nodularity in HFD KO vs WT male livers. Percentages in each panel refer to the percentage of liver weight. (*C*) Male, but not female, KO mice (19--24 weeks of age) showed reduced body mass compared with their WT counterparts after HFD feeding. The mean body mass for each group is shown below each graph. (\*\*\**P* \< .001 for WT vs KO males; NS, no significant difference for WT vs KO females). (*D*) Serum triglyceride levels for male and female KO mice were equivalent to WT counterparts (\**P* \< .05 for Het vs KO). Males were between 23 and 29 weeks of age, and females were between 27 and 31 weeks of age.

Fatty Acid Metabolism Genes Are Up-Regulated Constitutively in Hepatocytes From Lamin A/C-Deficient Male Livers {#sec2.3}
---------------------------------------------------------------------------------------------------------------

To understand the molecular basis of the male-specific hepatic steatosis phenotype, we performed expression profiling of *Lmna* WT, Het, and KO male livers from mice fed ND or HFD. Numerous genes encoding proteins involved in lipid storage and metabolism were up-regulated in KO livers ([Figure 7](#fig7){ref-type="fig"}*A*). In fact, the most highly up-regulated gene in male, but not female, livers was *Cidea* ([Figure 7](#fig7){ref-type="fig"}*B* and *C*), which encodes a lipid droplet--associated protein that promotes hepatic steatosis.[@bib41], [@bib42] The gene encoding cell death-inducing DNA fragmentation factor, a subunit-like effector C, a related lipid droplet--associated protein, also was highly up-regulated in lamin A/C KO male mouse livers after HFD feeding ([Figure 7](#fig7){ref-type="fig"}*B*), although there was no significant difference between male and female KO livers under ND feeding conditions ([Figure 7](#fig7){ref-type="fig"}*C*). We were not able to validate the up-regulation of these genes at the protein level owing to inefficient reactivity or high background of several tested antibodies (not shown). Other notable male KO liver up-regulated genes related to lipid metabolism included *Sptlc3*, *B4galt6*, and *Serinc2*, which encode proteins involved in sphingolipid biosynthesis; and *Fads3* and *Mogat1*, which encode proteins involved in fatty acid and triglyceride biosynthesis ([Figure 7](#fig7){ref-type="fig"}*A*). *Mogat1*, which encodes an enzyme that converts monoacylglycerol to diacylglycerol and is up-regulated in the livers of both lipodystrophic and *ob*/*ob* mice,[@bib43], [@bib44] was highly up-regulated in lamin A/C-deficient livers, and the up-regulation was enhanced further after HFD feeding ([Figure 7](#fig7){ref-type="fig"}*B* and *C*). Similarly, the fatty acid translocase CD36, which is up-regulated in the livers of patients with NAFLD and in mice after HFD feeding,[@bib45], [@bib46] was increased in *Lmna*-deficient male livers under both ND and HFD conditions ([Figure 7](#fig7){ref-type="fig"}*B*).Figure 7**Fatty acid metabolism genes are up-regulated in *Lmna*-deficient livers in a male-specific manner.** (*A*) *Lmna* Het and KO livers (3 each) from male mice fed ND were compared using Affymetrix microarrays. Het and KO livers were isolated from 26-week-old and 39-week-old mice, respectively. Genes that were significantly different in Het vs KO and carried the gene ontology term *fatty acid* were grouped together in a heat map (red, high expression; blue, low expression). *Cidea*, a gene that encodes a lipid binding protein, and *Hsd3b5*, a male-specific gene involved in steroid metabolism, were the most highly up-regulated and down-regulated genes, respectively, in *Lmna* KO male livers. (*B*) qPCR analysis of messenger RNA from WT/Het/KO male livers of mice (20--25 weeks old) fed ND or HFD (\**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001, and \*\*\*\**P* \< .0001); n = 3--4 livers per genotype group for the ND or the HFD feeding. (*C*) qPCR analysis of messenger RNA from WT/Het/KO livers from male and female mice (13--17 weeks old; n = 3--4 mice/genotype) fed a ND (\**P* \< .05). *Error bars* in all graphs represent SEM. Statistical significance was determined using 1-way analysis of variance followed by the Tukey post hoc test.

*Lmna* Deficiency Promotes Steatohepatitis and Fibrosis With Up-Regulation of Proinflammatory Genes {#sec2.4}
---------------------------------------------------------------------------------------------------

Given that progressive inflammation and fibrosis are thought to be the primary drivers of liver-related morbidity and mortality in human NAFLD, we tested whether lamin A/C KO livers also harbor inflammation and progress from simple steatosis to steatohepatitis and fibrosis. The expression profiling analysis showed that even with ND feeding, the lamin A/C KO livers manifested up-regulation of genes related to immunity and the interferon response ([Figure 8](#fig8){ref-type="fig"}*A*), including *Oas1*, *Oasl2*, *Oas2*, *Ifit1*, *Ifit2*, *Ddx60*, and *Dhx58* (which encode interferon-induced antiviral proteins); *Irf7*, which encodes an interferon-inducible transcription factor that promotes lipid accumulation; the chemokine receptor Cx3cr1; the ubiquitin-like modifier Ubd, which is involved in tumor necrosis factor α--induced nuclear factor-κB activation; and the thymocyte-expressed protein Themis, which is involved in thymocyte selection. A subset of the immune-related genes identified in the microarray, as well as *Tnfa*, were validated using qPCR of RNA isolated from livers of ND- and HFD-fed male mice ([Figure 8](#fig8){ref-type="fig"}*B*). Notably, all of the analyzed proinflammatory genes were up-regulated in KO livers under both ND and HFD conditions ([Figure 8](#fig8){ref-type="fig"}*B*).Figure 8**Hepatocyte-specific *Lmna*-deficiency promotes liver inflammation.** (*A*) Three *Lmna* Het and 3 *Lmna* KO livers from male mice fed a normal diet were compared using Affymetrix microarrays (same as those described in [Figure 7](#fig7){ref-type="fig"}). Het and KO livers were isolated from 26-week-old and 39-week-old mice, respectively. Transcripts that were significantly different and carried the gene ontology term *immune* were grouped together in a heat map (red, high expression; blue, low expression as compared with the mean values for the WT livers). *Black arrows* denote interferon-regulated genes that are up-regulated in KO livers. The *red arrow* indicates up-regulated Stat1 expression in KO livers. (*B*) qPCR analysis of messenger RNA from livers of WT and KO male mice (23--28 weeks old, 5 livers/genotype) fed ND or HFD. Expression of the indicated inflammation-associated genes is shown (\**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001, and \*\*\*\**P* \< .0001). *Error bars* in all graphs represent SEM. Statistical significance was determined using 1-way analysis of variance followed by the Tukey post hoc test. (*C*) Immunohistochemical staining of CD45+ cells in WT and KO liver sections from mice fed ND (WT liver: 27 weeks of age; KO liver: 24 weeks of age) or HFD (23 weeks of age for both WT and KO) (representative images are shown; n ≥ 3 mouse livers/genotype/condition). *Scale bars*: 50 μm.

Consistent with the observed increase in transcription of immune-related genes in KO livers, there was increased inflammatory cell infiltration in KO livers under both ND and HFD conditions, as assessed by CD45 staining ([Figure 8](#fig8){ref-type="fig"}*C*), consistent with steatohepatitis. Indeed, we also noted an increase in fibrosis in livers of HFD-fed KO mice, as evidenced by Picrosirius red staining and hydroxyproline measurement ([Figure 9](#fig9){ref-type="fig"}*A* and *B*), which became more severe with age ([Figure 9](#fig9){ref-type="fig"}*B*) and correlated with up-regulation of fibrosis-related genes in KO livers ([Figure 9](#fig9){ref-type="fig"}*C*). Although up-regulation of inflammation-related genes in KO livers was similar under ND and HFD conditions, up-regulation of fibrosis-related genes in KO livers was much more pronounced after HFD feeding ([Figure 9](#fig9){ref-type="fig"}*C*).Figure 9**Hepatic *Lmna* deficiency promotes liver fibrosis.** (*A*) Picrosirius red staining of paraffin sections of WT and KO livers from HFD-fed mice at 23 weeks of age. *Arrows* indicate fibrosis. *Scale bars*: 200 μm. Hydroxyproline measurement of liver extracts is shown (4--6 livers/genotype) (\**P* = .05). The statistical comparison was performed using the unpaired *t* test (2-tailed), and *error bars* represent SD. Quantitation of Picrosirius red--stained area in WT (n = 3) and KO (n = 4) livers from 23-week-old HFD-fed mice was performed as described in the Materials and Methods section. *Error bars* represent SD. NS indicates no significant difference between WT vs KO. Statistical significance was determined using the unpaired *t* test (2-tailed). (*B*) Picrosirius red (PSR) staining of paraffin sections of WT (n = 10) and KO (n = 9) livers from HFD-fed mice between 30 and 35 weeks of age. *Scale bars*: 200 μm. Quantitation was performed as described in the Materials and Methods section. Statistical significance (\*\*\*\**P* \< .0001) was determined using the unpaired *t* test (2-tailed), and error bars represent SD. (*C*) qPCR analysis of messenger RNA comparing WT and KO male livers (23--28 weeks old, 5 livers/genotype) fed ND or HFD for the expression of the indicated fibrosis-associated genes (\**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001, and \*\*\*\**P* \< .0001). *Error bars* in all qPCR graphs represent SEM. Statistical significance for qPCR analysis was determined using 1-way analysis of variance followed by the Tukey post hoc test.

*Lmna* Deficiency Causes Up-Regulated Stat1 Expression and Phosphorylation in Hepatocytes {#sec2.5}
-----------------------------------------------------------------------------------------

Expression profiling analysis indicated that a large proportion of immune genes that are up-regulated in KO livers comprise interferon-regulated genes, suggesting that *Lmna* deficiency dysregulates interferon α/β receptor signaling ([Figure 8](#fig8){ref-type="fig"}*A*, interferon-regulated genes are denoted with arrows). Stat1, a key transcription factor downstream of the interferon α/β receptor and important in the modulation of interferon-regulated gene expression,[@bib47] is up-regulated in KO livers at the messenger RNA and protein levels ([Figures 8](#fig8){ref-type="fig"}*A* and [10](#fig10){ref-type="fig"}*A* and *B*) under both ND and HFD feeding. There is also a dramatic increase in Stat1 Y701 phosphorylation in male KO vs WT livers ([Figure 10](#fig10){ref-type="fig"}*B*). In contrast, WT and KO female livers showed equivalent Stat1 protein expression, indicating that the phenotype is gender-specific ([Figure 10](#fig10){ref-type="fig"}*C*). The increase in Stat1 protein levels also was observed in primary hepatocytes from male mice, indicating that *Lmna* deficiency acts cell-autonomously to increase Stat1 protein in hepatocytes ([Figure 10](#fig10){ref-type="fig"}*D*).Figure 10**Hepatic *Lmna* deficiency causes up-regulation of Stat1 expression and phosphorylation in male liver.** (*A*) Stat1 qPCR analysis of messenger RNA from WT/Het/KO male livers of mice (age, 20--25 wk) fed ND or HFD (\**P* \< .05 and \*\*\**P* \< .001); n = 3--4 livers per genotype group for the ND or the HFD feeding. *Error bars* represent SEM. Statistical significance was determined using 1-way analysis of variance followed by the Tukey post hoc test. (*B*) Cytoplasmic liver extracts were prepared from WT and KO male mice (age, 23--28 wk) and then analyzed by phosphorylated Stat1 and Stat1 immunoblotting. (*C*) Cytoplasmic liver extracts were prepared from WT and KO female mice (age, 23--28 wk) and then analyzed by immunoblotting as indicated. (*D*) Primary hepatocytes (2 independent isolations are shown) were obtained from WT and KO male mice between 8 and 12 weeks of age, serum-starved for 8--12 hours, treated with 0 or 250 ng/mL of human GH (37°C, 10 min), and then lysed to prepare cytoplasmic extracts for immunoblotting. Note that KO male hepatocytes expressed higher levels of Stat1 than their WT counterparts.

*Lmna* Deficiency Causes Defects in GH Signaling and Aberrant Regulation of Sexually Dimorphic Genes in Hepatocytes {#sec2.6}
-------------------------------------------------------------------------------------------------------------------

The male specificity of the hepatic *Lmna* KO phenotype suggested that the male-specific pattern of hepatic gene expression might be disrupted in KO livers. GH signaling is known to regulate sexually dimorphic gene expression in hepatocytes, as evidenced by the induction of male-specific genes by pulsatile GH secretion (in contrast to continuous secretion in females) and resultant hepatocyte activation of Stat5b, and to a lesser extent Stat5a.[@bib26], [@bib28], [@bib29], [@bib30] Liver-specific Stat5ab deficiency abolishes growth hormone--mediated induction of male-specific genes, with relative preservation of female-specific gene expression, and de-represses female-specific gene expression in male livers.[@bib48], [@bib49], [@bib50] Interestingly, *Hsd3b5*, a male-specific hepatic gene that is Stat5ab-dependent, was the most highly down-regulated gene in male KO livers ([Figure 7](#fig7){ref-type="fig"}*A*), suggesting that GH/Stat5ab signaling might be altered in *Lmna* KO livers. We tested this hypothesis by examining the relative expression of Stat5ab-dependent, male-specific genes in WT and KO livers. Similar to Stat5ab-deficient livers, *Lmna* deficiency greatly reduced male-specific gene expression in male livers, but had no effect on the expression of these genes in females ([Figure 11](#fig11){ref-type="fig"}*A*). Not all Stat5ab-dependent genes were affected to the same degree by *Lmna* deficiency because liver insulin-like growth factor 1 (*Igf-1*) transcripts were equivalent in WT and KO livers ([Figure 11](#fig11){ref-type="fig"}*A*), and female-specific genes that are de-repressed by Stat5ab KO in male livers were affected only modestly in male *Lmna* KO livers ([Figure 11](#fig11){ref-type="fig"}*B*).Figure 11**Male-specific gene expression is compromised in *Lmna*-deficient livers.** (*A*) qPCR analysis of liver messenger RNA from male and female mice (age, 14--17 wk) show that WT male livers express significantly higher levels of male-specific genes than female livers and that *Lmna* deficiency significantly reduces expression of these genes in male livers. (*B*) qPCR analysis comparing *Lmna* WT and KO livers from male and female mice (age, 14--17 wk) for the expression of female-specific hepatic genes (note the marginal effect of *Lmna* deficiency on the expression of female-specific genes in male KO livers). (*A* and *B*) n = 4/genotype for male WT vs KO mice, and n = 3/genotype for female WT vs KO mice. *Error bars* in all qPCR graphs represent SEM. \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001, and \*\*\*\**P* \< .0001. Statistical significance for qPCR analysis was determined using 1-way analysis of variance followed by the Tukey post hoc test.

To assess whether *Lmna* deficiency impacted Stat5 activation via growth hormone signaling, primary hepatocytes from *Lmna* WT and KO livers were treated with varying concentrations of human GH. KO hepatocytes from male ([Figure 12](#fig12){ref-type="fig"}*A*) and female livers ([Figure 12](#fig12){ref-type="fig"}*B*) showed a decrease in Stat5 Y694 phosphorylation, which corresponded with decreased translocation of Stat5 to the nucleus in KO hepatocytes.Figure 12**GH signaling is compromised in *Lmna*-deficient hepatocytes and livers.** (*A*) Primary hepatocytes were isolated from 8- to 12-week-old WT and KO male mice, serum-starved for 8--12 hours, treated with 0, 25, 50, or 250 ng/mL of human GH (37°C, 10 min), and then lysed to prepare cytoplasmic and nuclear extracts for immunoblotting. Primary hepatocyte isolation experiments were repeated 5 times, and results shown are representative. (*B*) Primary hepatocytes were isolated from 8- to 12-week-old WT and KO female mice, serum-starved for 8--12 hours, treated with 0, 50, or 250 ng/mL of human GH (37°C, 10 min), and then lysed to prepare cytoplasmic and nuclear extracts for immunoblotting. Primary hepatocyte isolation experiments were repeated 2 times. (*C*) Cytoplasmic liver extracts were prepared from WT and KO male mice (20--24 weeks old) that were injected intraperitoneally with either PBS or GH (2.5 mg/kg). Livers were harvested 10 minutes after injection. Extracts then were analyzed by immunoblotting as indicated in the Materials and Methods section. (*D*) Relative band intensities for phosphorylated and total Jak2, Akt, Stat5, and Erk for immunoblots shown in panel *C* were determined using ImageJ software, and relative band intensities for the phosphorylated proteins were normalized to total Jak2, Akt, Stat5, or Erk. Note that GH induced Jak2, Stat5, and Erk phosphorylation in WT but not KO livers. \*\**P* \< .01 for WT PBS vs GH for phosphorylated Stat5 and phosphorylated Erk analysis, and \*\*\*\**P* \< .0001 for WT PBS vs GH for phosphorylated Jak2 analysis. *Error bars* in all graphs represent SD. Statistical significance was determined using 1-way analysis of variance followed by the Tukey post hoc test.

In addition to primary hepatocytes, we observed decreased induction of Jak2 Y1007/Y1008, Stat5 Y694, and Erk T202/Y204 phosphorylation in male *Lmna* KO livers after GH administration ([Figure 12](#fig12){ref-type="fig"}*C* and *D*). In contrast, there was no significant induction of Akt S473 in response to GH in either WT or KO livers, suggesting that Jak2, Stat5, and Erk are the primary pathways downstream of GH that are altered in the hepatocyte-specific lamin A/C KO model ([Figure 12](#fig12){ref-type="fig"}*C* and *D*).

Discussion {#sec3}
==========

Our data indicate that hepatocyte *Lmna* deficiency leads to the following: (1) alteration in nuclear shape; (2) male-selective spontaneous steatosis under normal feeding conditions with increased age-associated susceptibility to HFD-induced steatohepatitis and fibrosis; (3) a blunted response to GH in hepatocytes characterized by reduced induction of Jak2, Stat5, and Erk phosphorylation; (4) decreased expression of a subset of Stat5-dependent, GH-induced genes; and (5) increased hepatic Stat1 expression and phosphorylation in a male-specific manner ([Figure 13](#fig13){ref-type="fig"}). There are several likely contributors to our observed phenotype, including the marked up-regulation of *Cidea* and other lipogenic genes in response to lamin A/C absence, given their known function in fatty liver disease development. In addition, the up-regulation of CD36 that we observe meshes well with the known role of CD36 in promoting hepatic steatosis and insulin resistance.[@bib45], [@bib51] Notably, CD36 also is up-regulated in hepatocyte-specific GH-receptor--, Jak2-, and Stat5-deficient mice, suggesting that dysregulated hepatic growth hormone signaling might be responsible for CD36 up-regulation in *Lmna*-deficient hepatocytes because Stat5 previously was shown to repress CD36 transcription directly.[@bib52], [@bib53], [@bib54], [@bib55], [@bib56] Similar to hepatocyte-specific Stat5ab-deficient mice, our KO mice showed body mass loss.[@bib48], [@bib50] In addition, *Lmna*-deficient livers showed similar decreases in the expression of male-specific hepatic genes as Stat5ab-deficient livers.[@bib48], [@bib50] Both male and female KO hepatocytes showed decreased Stat5 phosphorylation and nuclear translocation in response to GH treatment. The greater severity of the *Lmna* KO phenotype in male vs female livers may be owing to the greater effect hepatocyte-specific Stat5 deficiency has on male- vs female-specific hepatic gene expression.[@bib49], [@bib50]Figure 13**Absence of lamin A/C in hepatocytes interferes with GH signaling in male hepatocytes.** The schematic summarizes our findings. *Lmna* deficiency is responsible for the following: (1) alters nuclear shape; (2) inhibits growth hormone receptor--mediated Jak2, Stat5, and Erk phosphorylation; (3) decreases the expression of Stat5-dependent male-specific genes; (4) increases expression of the Stat5-regulated fatty acid translocator CD36, (5) up-regulates *Cidea* transcription, and (6) increases Stat1 messenger RNA and protein expression and activation, resulting in the induction of interferon-regulated genes. These alterations lead to hepatocyte storage of excess fatty acids with consequent induction of hepatic inflammation and fibrosis upon feeding with a HFD.

It is important to note that not all aspects hepatic GHR-, Jak2-, and Stat5ab-deficiency are recapitulated in our model. For example, we did not observe a difference in hepatic *Igf-1* transcript levels between WT and KO mice, as had been reported in the other models.[@bib52], [@bib53], [@bib54], [@bib55], [@bib56] The decreased serum IGF-1 and the resultant increased serum GH levels in hepatic Jak2- and Stat5-deficient mice are thought to increase serum triglyceride levels by GH-induced lipolysis in adipocytes. In these animals, hepatic steatosis was observed by 15 weeks of age. Hepatic *Lmna*-deficient mice, on the other hand, showed no increase in serum triglyceride levels or hepatic steatosis at 15 weeks in ND-fed animals, and serum triglyceride levels in KO males were equivalent to WT after HFD feeding, despite increased hepatic steatosis. These differences in phenotype likely reflect normal hepatic *Igf-1* expression in hepatic *Lmna*-deficient mice ([Figure 11](#fig11){ref-type="fig"}*A*), despite the dysregulation of Stat5 signaling. Similarly, hepatic *Lmna* deficiency had a reduced effect on the expression of female-specific genes in male livers compared with hepatic Stat5ab deficiency, in which female-specific genes are de-repressed.[@bib49], [@bib50] Taken together, these data indicate that there are qualitative and/or quantitative differences in Stat5 signaling in *Lmna*-deficient livers that affect male-specific hepatic gene expression, but not all Stat5-dependent genes.

Loss of hepatocyte Stat5 expression results in increased levels of total and Y701 phosphorylated Stat1.[@bib53] Increased Stat1 expression and phosphorylation positively regulate interferon α/β receptor signaling.[@bib57], [@bib58] These findings support our hypothesis that the increased Stat1 levels, interferon-regulated gene expression, and inflammation in male KO livers likely are the result of dysregulation of Stat5 signaling as a result of *Lmna* deficiency. Our data are consistent with a model in which lamin A/C represses the activation of steatosis-, inflammation-, and fibrosis-related genes in the liver by positively regulating GH-induced Stat5 signaling ([Figure 13](#fig13){ref-type="fig"}).

GH-induced Erk signaling also is compromised in male KO hepatocytes ([Figure 12](#fig12){ref-type="fig"}*C* and *D*), but the potential role that Erk plays in the *Lmna* KO liver phenotype is unknown. GH induces Erk phosphorylation through Jak2-mediated phosphorylation of the adaptor protein Shc[@bib59] and also through a Jak2-independent/Src-dependent pathway.[@bib60], [@bib61] Of note, transgenic mice that express a human *LMNA* allele that causes dilated cardiomyopathy show increased Erk activation in heart tissue, and pharmacologic inhibition of Erk phosphorylation ameliorates the cardiomyopathy phenotype.[@bib62], [@bib63], [@bib64] This is in contrast to our system, in which we see blunted Erk activation in *Lmna*-deficient livers. It is important to note that expression of a disease-causing lamin A/C variant, with potential gain-of-function effects (with or without loss-of-function effects), could have different cellular consequences compared with absence of lamin A/C.

The male-specific steatohepatitis phenotype in the *Lmna* KO mice is reminiscent of the gender differences observed in some instances of human NAFLD and in some of the laminopathies. For example, studies from the United States and China have indicated a higher prevalence of NAFLD in men than in premenopausal women, and there also have been variations among different ethnicities.[@bib65], [@bib66] However, in the case of FPLD2, female patients are affected more prominently than males in terms of the diabetes phenotype,[@bib16] but the liver phenotype was not assessed in the studied cohort. Our findings are highly relevant to human fatty liver disease, in which relatively few genetic variants that contribute to disease development and progression have been defined.[@bib67] In this context, we posit that lamin A/C variants may contribute to fatty liver disease progression. There is already clear evidence to support this hypothesis because patients with FPLD2 caused by lamin A/C mutation also develop hepatosteatosis.[@bib68] However, given the multi-organ involvement of this familial lipodystrophy, it has not been clear whether the liver disease is related to direct lamin-related effects on the hepatocyte or a secondary effect of the metabolic syndrome. The findings described herein help answer this question by showing that hepatocyte-specific ablation of lamin A/C in mice leads to fatty liver disease and also provide support for lamins playing a role in normal hepatocyte homeostasis.
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